Superiority of combined diltiazem and propranolol therapy for angina pectoris.
Authors:
- W E StraussWSW E Strauss
- A F ParisiAPA F Parisi
- 1 May 1985
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 71 (5) , 951-957
Abstract
Twenty-four patients with stable angina were evaluated in a 14 week crossover trial. A single-blind placebo period (baseline 1) was followed by two double-blind periods evaluating maximum tolerated doses of diltiazem (up to 360 mg daily) vs placebo. Over the next 1 to 4 weeks, propranolol was started and increased until clinically documented beta-blockade was achieved (baseline 2). The final phase consisted of a pair of evaluation periods comparing propranolol plus the maximum tolerated dose of diltiazem to propranolol and placebo. The daily rate of angina attack was 1.6 during baseline, was unchanged during placebo therapy, but fell during treatment with diltiazem to 0.6 (p less than .005). With the addition of diltiazem to propranolol, the angina rate was improved (0.3) compared with that with either propranolol alone (0.6) or propranolol and placebo (0.5) (p less than .01). Total exercise duration during baseline 1 was 360 sec and increased to 497 sec with diltiazem, 481 sec with propranolol, and 527 sec with the combination of diltiazem and propranolol. Two patients with reduced ejection fractions developed congestive heart failure with propranolol. The combination of diltiazem and propranolol similarly resulted in congestive heart failure in one patient who had tolerated both drugs alone.Keywords
This publication has 19 references indexed in Scilit:
- Randomized, placebo-controlled evaluation of lidoflazine in patients receiving beta-blocker therapy with propranolol: Improvement in anginal symptoms and exercise tolerance with combined drug therapyThe American Journal of Cardiology, 1984
- Efficacy of diltiazem in angina on effort: A multicenter trialThe American Journal of Cardiology, 1982
- Safety and efficacy of diltiazem hydrochloride for the treatment of stable angina pectoris: Report of a cooperative clinical trialThe American Journal of Cardiology, 1982
- Differential cardiovascular effects of calcium channel blocking agents: Potential mechanismsThe American Journal of Cardiology, 1982
- Combined therapy with verapamil and propranolol in chronic stable anginaThe American Journal of Cardiology, 1982
- Differential effects of systemic and intracoronary calcium channel blocking agents on global and regional left ventricular function in conscious dogsAmerican Heart Journal, 1981
- Clinical efficacy of verapamil alone and combined with propranolol in treating patients with chronic stable angina pectorisThe American Journal of Cardiology, 1981
- Influence of severity of ventricular dysfunction on hemodynamic responses to intravenously administered verapamil in ischemic heart diseaseThe American Journal of Cardiology, 1981
- Nifedipine and left ventricular function in beta-blocked patients.Heart, 1981
- VERAPAMIL IN CHRONIC STABLE ANGINAThe Lancet, 1980